Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M Glanz

Showing results (91-100 of 146) with videos related to

Pageof 15
Sort By:
Archives of Pathology & Laboratory Medicine|October 5, 2023
SARS-CoV-2 Serology Did Not Predict Risk of Breakthrough Infection During the Omicron BA.1 and BA.2 SurgeKatia J Bruxvoort, Jiaxiao Shi, Hubert Song, et al.
MMWR. Morbidity and Mortality Weekly Report|December 8, 2022
Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak - United States, May 22-October 21, 2022Jonathan Duffy, Paige Marquez, Pedro Moro, et al.
Archives of Pediatrics & Adolescent Medicine|November 3, 2004
Safety of the trivalent inactivated influenza vaccine among children: a population-based studyEric K France, Jason M Glanz, Stanley Xu, et al.
Influenza and Other Respiratory Viruses|September 30, 2017
Estimated rates of influenza-associated outpatient visits during 2001-2010 in 6 US integrated healthcare delivery organizationsHong Zhou, William W Thompson, Edward A Belongia, et al.
Pharmacoepidemiology and Drug Safety|June 5, 2018
Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescentsMichael L Jackson, Onchee Yu, Jennifer C Nelson, et al.
BMC Pulmonary Medicine|December 17, 2017
Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adultsAaron D Storms, Jufu Chen, Lisa A Jackson, et al.
Vaccine|April 5, 2014
Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccineMatthew F Daley, W Katherine Yih, Jason M Glanz, et al.
Academic Pediatrics|April 1, 2018
Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization ScheduleMatthew F Daley, Jo Ann Shoup, Sophia R Newcomer, et al.
Vaccine|April 13, 2013
Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in childrenHung Fu Tseng, Lina S Sy, In-Lu Amy Liu, et al.
The Pediatric Infectious Disease Journal|February 8, 2020
Order of Live and Inactivated Vaccines and Risk of Non-vaccine-targeted Infections in US Children 11-23 Months of AgeSophia R Newcomer, Matthew F Daley, Komal J Narwaney, et al.
Pageof 15

Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
Archives of Pathology & Laboratory Medicine|October 5, 2023
SARS-CoV-2 Serology Did Not Predict Risk of Breakthrough Infection During the Omicron BA.1 and BA.2 SurgeKatia J Bruxvoort, Jiaxiao Shi, Hubert Song, et al.
MMWR. Morbidity and Mortality Weekly Report|December 8, 2022
Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak - United States, May 22-October 21, 2022Jonathan Duffy, Paige Marquez, Pedro Moro, et al.
Archives of Pediatrics & Adolescent Medicine|November 3, 2004
Safety of the trivalent inactivated influenza vaccine among children: a population-based studyEric K France, Jason M Glanz, Stanley Xu, et al.
Influenza and Other Respiratory Viruses|September 30, 2017
Estimated rates of influenza-associated outpatient visits during 2001-2010 in 6 US integrated healthcare delivery organizationsHong Zhou, William W Thompson, Edward A Belongia, et al.
Pharmacoepidemiology and Drug Safety|June 5, 2018
Safety of repeated doses of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine in adults and adolescentsMichael L Jackson, Onchee Yu, Jennifer C Nelson, et al.
BMC Pulmonary Medicine|December 17, 2017
Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adultsAaron D Storms, Jufu Chen, Lisa A Jackson, et al.
Vaccine|April 5, 2014
Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccineMatthew F Daley, W Katherine Yih, Jason M Glanz, et al.
Academic Pediatrics|April 1, 2018
Assessing Potential Confounding and Misclassification Bias When Studying the Safety of the Childhood Immunization ScheduleMatthew F Daley, Jo Ann Shoup, Sophia R Newcomer, et al.
Vaccine|April 13, 2013
Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in childrenHung Fu Tseng, Lina S Sy, In-Lu Amy Liu, et al.
The Pediatric Infectious Disease Journal|February 8, 2020
Order of Live and Inactivated Vaccines and Risk of Non-vaccine-targeted Infections in US Children 11-23 Months of AgeSophia R Newcomer, Matthew F Daley, Komal J Narwaney, et al.
Pageof 15